Dec. 08, 2018 10:15 AM – San Lazzaro di Savena – Bologna (IT)
Angiodroid Srl, the italian medical device company focused on the design, development and marketing of the only carbon dioxide automatic injector for angiography, has signed the final agreement with the Italian Revenue Agency to access the Patent Box tax relief.
The Italian Patent Box regime provides for a tax relief for a five-year period from 2015 to 2019 that will be extended to period 2020-2024.
The estimated tax benefit by the 99.8% of profits will be fully reflected in the company results as previous years income tax adjustment and the tax benefits for 2018 and 2019 will be quantified and disclosed in the company financial statements of such respective years.
To achieve this very important result Angiodroid Srl have been supported by Michele Davalli, senior partner at Studio Davalli.
We are sorry, you can access this content only if you are an Healthcare Professionist.
Angiodroid adopted this restrictions in accordance with the Italian regulations on sponsorship of medical devies (art. 21 of D.L. 24.02.97, n.46; 93/42/CEE directive; guidelines 17.02.2010)